XGN
Exagen IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$112.83M
P/E Ratio
—
EPS
$-0.90
Beta
2.02
52W High
$12.23
52W Low
$2.59
50-Day MA
$3.61
200-Day MA
$6.20
Dividend Yield
—
Profit Margin
-29.50%
Forward P/E
—
PEG Ratio
—
About Exagen Inc
Exagen Inc. develops and markets various test products based on its Cell-Bound Complement Activation Products technology under the AVISE brand name in the United States. The company is headquartered in Vista, California.
Fundamentals
| Revenue (TTM) | $68.38M |
| Gross Profit (TTM) | $39.88M |
| EBITDA | $-11.84M |
| Operating Margin | -19.70% |
| Return on Equity | -193.60% |
| Return on Assets | -19.10% |
| Revenue/Share (TTM) | $2.99 |
| Book Value | $0.60 |
| Price-to-Book | 7.50 |
| Price-to-Sales (TTM) | 1.65 |
| EV/Revenue | 1.639 |
| EV/EBITDA | -0.16 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 11.70% |
| Shares Outstanding | $24.16M |
| Float | $13.81M |
| % Insiders | 28.26% |
| % Institutions | 53.03% |
Historical Volatility
HV 10-Day
108.87%
HV 20-Day
100.72%
HV 30-Day
127.21%
HV 60-Day
99.27%
HV Rank
99.6%
Volatility is currently contracting
Analyst Ratings
Consensus ($8.67 target)
7
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026